{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T18:16:10Z","timestamp":1794075370633,"version":"4.8.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["cgfr.co.uk","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.cytogfr.2013.04.003","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T04:00:57Z","timestamp":1368590457000},"page":"203-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":434,"title":["The BAFF\/APRIL system: Emerging functions beyond B cell biology and autoimmunity"],"prefix":"10.1016","volume":"24","author":[{"given":"Fabien B.","family":"Vincent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Saulep-Easton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Figgett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten A.","family":"Fairfax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2013.04.003_bib0005","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1084\/jem.190.11.1697","article-title":"Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations","volume":"190","author":"Mackay","year":"1999","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0010","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0015","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/icb.2011.111","article-title":"BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus","volume":"90","author":"Vincent","year":"2012","journal-title":"Immunology and Cell Biology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012993","article-title":"Genetic and molecular functional characterization of variants within TNFSF13B, a positional candidate preeclampsia susceptibility gene on 13q","volume":"5","author":"Fenstad","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0025","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.2353\/ajpath.2008.071139","article-title":"Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta","volume":"172","author":"Langat","year":"2008","journal-title":"American Journal of Pathology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0030","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1084\/jem.188.6.1185","article-title":"APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth","volume":"188","author":"Hahne","year":"1998","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1182\/blood.V97.1.198","article-title":"Synthesis and release of B-lymphocyte stimulator from myeloid cells","volume":"97","author":"Nardelli","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0040","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/eji.201040591","article-title":"Mutation of the BAFF furin cleavage site impairs B-cell homeostasis and antibody responses","volume":"41","author":"Bossen","year":"2011","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0045","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/embo-reports\/kve198","article-title":"Biologically active APRIL is secreted following intracellular processing in the Golgi apparatus by furin convertase","volume":"2","author":"Lopez-Fraga","year":"2001","journal-title":"EMBO Reports"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0050","doi-asserted-by":"crossref","first-page":"e20787","DOI":"10.1371\/journal.pone.0020787","article-title":"Aberrant expression of functional BAFF-system receptors by malignant B-cell precursors impacts leukemia cell survival","volume":"6","author":"Maia","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0055","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1093\/emboj\/cdf565","article-title":"An endogenous hybrid mRNA encodes TWE-PRIL, a functional cell surface TWEAK-APRIL fusion protein","volume":"21","author":"Pradet-Balade","year":"2002","journal-title":"EMBO Journal"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0060","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1182\/blood-2007-09-110874","article-title":"TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts","volume":"111","author":"Bossen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0065","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0092-8674(02)00631-1","article-title":"Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands","volume":"108","author":"Liu","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0070","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1021\/bi051685o","article-title":"Formation of virus-like clusters is an intrinsic property of the tumor necrosis factor family member BAFF (B cell activating factor)","volume":"45","author":"Cachero","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0075","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4049\/jimmunol.175.1.319","article-title":"deltaBAFF, a splice isoform of BAFF, opposes full-length BAFF activity in vivo in transgenic mouse models","volume":"175","author":"Gavin","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0080","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1084\/jem.20042309","article-title":"Identification of proteoglycans as the APRIL-specific binding partners","volume":"201","author":"Ingold","year":"2005","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0085","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1021\/bi048227k","article-title":"Selectivity of BAFF\/BLyS and APRIL for binding to the TNF family receptors BAFFR\/BR3 and BCMA","volume":"44","author":"Day","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0090","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.1001120","article-title":"The structure of the TNFRSF13C promoter enables differential expression of BAFF-R during B cell ontogeny and terminal differentiation","volume":"185","author":"Mihalcik","year":"2010","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0095","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.173.2.807","article-title":"B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells","volume":"173","author":"Ng","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0100","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s003350010125","article-title":"Molecular cloning and functional characterization of murine transmembrane activator and CAML interactor (TACI) with chromosomal localization in human and mouse","volume":"11","author":"von Bulow","year":"2000","journal-title":"Mammalian Genome"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0105","doi-asserted-by":"crossref","first-page":"1277e5","DOI":"10.1016\/j.jaci.2009.03.019","article-title":"Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells","volume":"123","author":"Ozcan","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0110","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1074-7613(03)00025-6","article-title":"Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor","volume":"18","author":"Seshasayee","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0115","doi-asserted-by":"crossref","first-page":"15401","DOI":"10.1073\/pnas.1200386109","article-title":"Deficiency in TNFRSF13B (TACI) expands T-follicular helper and germinal center B cells via increased ICOS-ligand expression but impairs plasma cell survival","volume":"109","author":"Ou","year":"2012","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0120","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/ni.1914","article-title":"The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88","volume":"11","author":"He","year":"2010","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0125","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-3083.2011.02651.x","article-title":"TACI expression is low both in human and mouse newborns","volume":"75","author":"Akkoyunlu","year":"2012","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0130","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jaci.2012.10.029","article-title":"TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes","volume":"131","author":"Martinez-Gallo","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.humimm.2012.05.001","article-title":"A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family","volume":"73","author":"Lougaris","year":"2012","journal-title":"Human Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0140","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1600-0609.2009.01262.x","article-title":"APRIL and TACI interact with syndecan-1 on the surface of multiple myeloma cells to form an essential survival loop","volume":"83","author":"Moreaux","year":"2009","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0145","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/ni.1666","article-title":"Tonic B cell antigen receptor signals supply an NF-kappaB substrate for prosurvival BLyS signaling","volume":"9","author":"Stadanlick","year":"2008","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0150","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20031330","article-title":"BCMA is essential for the survival of long-lived bone marrow plasma cells","volume":"199","author":"O\u2019Connor","year":"2004","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0155","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/ni.2527","article-title":"Mcl-1 is essential for the survival of plasma cells","volume":"14","author":"Peperzak","year":"2013","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0160","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1523\/JNEUROSCI.5040-08.2009","article-title":"Identification of BLyS (B lymphocyte stimulator), a non-myelin-associated protein, as a functional ligand for Nogo-66 receptor","volume":"29","author":"Zhang","year":"2009","journal-title":"Journal of Neuroscience"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.20041674","article-title":"BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma","volume":"201","author":"Krumbholz","year":"2005","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jneuroim.2013.01.001","article-title":"Intravenous immunoglobulin inhibits BAFF production in chronic inflammatory demyelinating polyneuropathy \u2013 a new mechanism of action?","volume":"256","author":"Bick","year":"2013","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0175","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.molimm.2012.06.013","article-title":"Murine BAFF expression is up-regulated by estrogen and interferons: implications for sex bias in the development of autoimmunity","volume":"53","author":"Panchanathan","year":"2013","journal-title":"Molecular Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0180","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.4049\/jimmunol.1000466","article-title":"B Cell and BAFF dependence of IFN-alpha-exaggerated disease in systemic lupus erythematosus-prone NZM 2328 mice","volume":"186","author":"Jacob","year":"2011","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0185","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1182\/blood-2012-06-438911","article-title":"B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways","volume":"120","author":"Allen","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0190","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1182\/blood-2008-09-177840","article-title":"Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease","volume":"113","author":"Sarantopoulos","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0195","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1182\/blood-2012-06-435008","article-title":"CD19+CD21low B-cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome","volume":"121","author":"Kuzmina","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0200","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood-2010-09-310011","article-title":"Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD","volume":"118","author":"Clark","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0205","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1182\/blood-2011-05-354019","article-title":"Circulating B-cell activating factor level predicts clinical response of chronic graft-versus-host disease to extracorporeal photopheresis","volume":"118","author":"Whittle","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0210","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.transproceed.2008.10.024","article-title":"Abnormal high expression of B-cell activating factor belonging to the TNF superfamily (BAFF) associated with long-term outcome in kidney transplant recipients","volume":"41","author":"Xu","year":"2009","journal-title":"Transplantation Proceedings"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0215","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1182\/blood-2010-07-295766","article-title":"Significant differences in B-cell subpopulations characterize patients with chronic graft-versus-host disease-associated dysgammaglobulinemia","volume":"117","author":"Kuzmina","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0220","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/10428194.2011.603448","article-title":"B cell homeostasis and the development of chronic graft-versus-host disease: implications for B cell-depleting therapy","volume":"53","author":"Kim","year":"2012","journal-title":"Leukemia and Lymphoma"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0225","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1182\/blood-2010-10-307819","article-title":"Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease","volume":"117","author":"Sarantopoulos","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0230","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4149\/neo_2011_03_211","article-title":"Overexpression of B cell-activating factor (BAFF) in neutrophils of oral cavity cancer patients \u2013 preliminary study","volume":"58","author":"Jablonska","year":"2011","journal-title":"Neoplasma"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1756-9966-31-31","article-title":"BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells","volume":"31","author":"Zhu","year":"2012","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0240","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.leukres.2012.03.012","article-title":"Serum BAFF levels are related to angiogenesis and prognosis in patients with multiple myeloma","volume":"36","author":"Fragioudaki","year":"2012","journal-title":"Leukemia Research"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0245","doi-asserted-by":"crossref","first-page":"18956","DOI":"10.1073\/pnas.1013420107","article-title":"B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia","volume":"107","author":"Zhang","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0250","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.4049\/jimmunol.1102066","article-title":"Stromal endothelial cells establish a bidirectional crosstalk with chronic lymphocytic leukemia cells through the TNF-related factors BAFF, APRIL, and CD40L","volume":"188","author":"Cols","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0255","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1600-0609.2010.01482.x","article-title":"Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia","volume":"85","author":"Molica","year":"2010","journal-title":"European Journal of Haematology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0260","doi-asserted-by":"crossref","first-page":"e50936","DOI":"10.1371\/journal.pone.0050936","article-title":"Expression of BAFF and BAFF-R in follicular lymphoma: correlation with clinicopathologic characteristics and survival outcomes","volume":"7","author":"Li","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0265","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1158\/1078-0432.CCR-08-1951","article-title":"The lack of epithelial interleukin-7 and BAFF\/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance","volume":"15","author":"Di Carlo","year":"2009","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0270","doi-asserted-by":"crossref","first-page":"A14","DOI":"10.1136\/ard.2010.129585j","article-title":"B cell activating factor of the TNF family: \u03944BAFF, an alternate-splice isoform that acts as a transcription factor and exaggerates its production in autoimmunity and cancer","volume":"69","author":"Le Pottier","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-2407-9-83","article-title":"APRIL is overexpressed in cancer: link with tumor progression","volume":"9","author":"Moreaux","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0280","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1182\/blood-2008-10-183467","article-title":"BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB\/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells","volume":"113","author":"Fu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0285","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1084\/jem.20100857","article-title":"A BAFF-R mutation associated with non-Hodgkin lymphoma alters TRAF recruitment and reveals new insights into BAFF-R signaling","volume":"207","author":"Hildebrand","year":"2010","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0290","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/leu.2011.286","article-title":"Phase 1b trial of atacicept, a recombinant protein binding BLyS and APRIL, in patients with chronic lymphocytic leukemia","volume":"26","author":"Kofler","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0295","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1038\/leu.2012.54","article-title":"Treatment of acute lymphoblastic leukemia with an rGel\/BLyS fusion toxin","volume":"26","author":"Parameswaran","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0300","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/leu.2010.261","article-title":"Selective killing of Burkitt's lymphoma cells by mBAFF-targeted delivery of PinX1","volume":"25","author":"Zhang","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0305","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1097\/00002030-200309050-00018","article-title":"Plasma levels of B-lymphocyte stimulator increase with HIV disease progression","volume":"17","author":"Rodriguez","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0310","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaut.2006.07.005","article-title":"Elevated serum B-lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: association with autoimmunity","volume":"27","author":"Toubi","year":"2006","journal-title":"Journal of Autoimmunity"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0315","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/thoraxjnl-2012-202288","article-title":"Respiratory syncytial virus infection of airway epithelial cells, in vivo and in vitro, supports pulmonary antibody responses by inducing expression of the B cell differentiation factor BAFF","volume":"68","author":"McNamara","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0320","doi-asserted-by":"crossref","first-page":"6408","DOI":"10.1128\/JVI.00213-12","article-title":"Endothelial cells elicit immune-enhancing responses to dengue virus infection","volume":"86","author":"Dalrymple","year":"2012","journal-title":"Journal of Virology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0325","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.4049\/jimmunol.171.10.5215","article-title":"EBV-encoded latent membrane protein 1 cooperates with BAFF\/BLyS and APRIL to induce T cell-independent Ig heavy chain class switching","volume":"171","author":"He","year":"2003","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0330","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000321194","article-title":"Induction of B cell-activating factor by viral infection is a general phenomenon, but the types of viruses and mechanisms depend on cell type","volume":"3","author":"Ittah","year":"2011","journal-title":"Journal of Innate Immunity"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0335","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/597386","article-title":"Innate immune signals modulate antiviral and polyreactive antibody responses during severe respiratory syncytial virus infection","volume":"199","author":"Reed","year":"2009","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0340","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1189\/jlb.1007675","article-title":"Stimulation of the primary anti-HIV antibody response by IFN-alpha in patients with acute HIV-1 infection","volume":"83","author":"Adalid-Peralta","year":"2008","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0345","doi-asserted-by":"crossref","first-page":"875821","DOI":"10.1155\/2012\/875821","article-title":"Natural immunity to HIV: a delicate balance between strength and control","volume":"2012","author":"Poudrier","year":"2012","journal-title":"Clinical & Developmental Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0350","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1172\/JCI57362","article-title":"Protective antiviral antibody responses in a mouse model of influenza virus infection require TACI","volume":"121","author":"Wolf","year":"2011","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0355","doi-asserted-by":"crossref","first-page":"5832","DOI":"10.1182\/blood-2011-05-353961","article-title":"TACI deficiency impairs sustained Blimp-1 expression in B cells decreasing long-lived plasma cells in the bone marrow","volume":"118","author":"Tsuji","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0360","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/ng1601","article-title":"TACI is mutant in common variable immunodeficiency and IgA deficiency","volume":"37","author":"Castigli","year":"2005","journal-title":"Nature Genetics"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0365","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(01)00130-3","article-title":"Regulation of the T-independent humoral response by TACI","volume":"14","author":"von Bulow","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0370","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1182\/blood-2007-01-069245","article-title":"Decreased expression of tumor necrosis factor family receptors involved in humoral immune responses in preterm neonates","volume":"110","author":"Kaur","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0375","doi-asserted-by":"crossref","first-page":"e38429","DOI":"10.1371\/journal.pone.0038429","article-title":"Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0380","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1002\/eji.201242689","article-title":"Malaria infection alters the expression of B-cell activating factor resulting in diminished memory antibody responses and survival","volume":"42","author":"Liu","year":"2012","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0385","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/infdis\/jir438","article-title":"The plasma concentration of the B cell activating factor is increased in children with acute malaria","volume":"204","author":"Nduati","year":"2011","journal-title":"Journal of Infectious Diseases"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0390","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/imj.12039","article-title":"Focus on systemic lupus erythematosus in Indigenous Australians: towards a better understanding of autoimmune diseases","volume":"43","author":"Vincent","year":"2013","journal-title":"Internal Medicine Journal"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0395","series-title":"GeneReviews","article-title":"Common variable immune deficiency overview","author":"Scharenberg","year":"2006"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0400","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1749-6632.2011.06338.x","article-title":"Perspectives on common variable immune deficiency","volume":"1246","author":"Park","year":"2011","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0405","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ng1600","article-title":"Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans","volume":"37","author":"Salzer","year":"2005","journal-title":"Nature Genetics"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0410","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jaci.2007.10.001","article-title":"Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes","volume":"120","author":"Zhang","year":"2007","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0415","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/ng0407-429","article-title":"Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency","volume":"39","author":"Pan-Hammarstrom","year":"2007","journal-title":"Nature Genetics"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0420","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1182\/blood-2009-05-213025","article-title":"Role of TNFRSF13B variants in patients with common variable immunodeficiency","volume":"114","author":"Martinez-Pomar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0425","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1172\/JCI31023","article-title":"Dominant-negative effect of the heterozygous C104R TACI mutation in common variable immunodeficiency (CVID)","volume":"117","author":"Garibyan","year":"2007","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0430","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.jaci.2011.02.037","article-title":"The C76R transmembrane activator and calcium modulator cyclophilin ligand interactor mutation disrupts antibody production and B-cell homeostasis in heterozygous and homozygous mice","volume":"127","author":"Bacchelli","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0435","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jaci.2010.08.017","article-title":"The C104R mutant impairs the function of transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI) through haploinsufficiency","volume":"126","author":"Lee","year":"2010","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0440","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(01)00130-3","article-title":"Regulation of the T-independent humoral response by TACI","volume":"14","author":"von Bulow","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0445","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/89790","article-title":"Activation and accumulation of B cells in TACI-deficient mice","volume":"2","author":"Yan","year":"2001","journal-title":"Nature Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0450","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s10875-005-5637-2","article-title":"Mutational analysis of human BAFF receptor TNFRSF13C (BAFF-R) in patients with common variable immunodeficiency","volume":"25","author":"Losi","year":"2005","journal-title":"Journal of Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0455","doi-asserted-by":"crossref","first-page":"13945","DOI":"10.1073\/pnas.0903543106","article-title":"B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans","volume":"106","author":"Warnatz","year":"2009","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0460","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/art.27189","article-title":"Effect of long-term belimumab treatment on B cells in systemic lupus erythematosus: extension of a phase II, double-blind, placebo-controlled, dose-ranging study","volume":"62","author":"Jacobi","year":"2010","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0465","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.4049\/jimmunol.174.9.5537","article-title":"BAFF augments certain Th1-associated inflammatory responses","volume":"174","author":"Sutherland","year":"2005","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0470","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/emm.2007.38","article-title":"TACI: Fc scavenging B cell activating factor (BAFF) alleviates ovalbumin-induced bronchial asthma in mice","volume":"39","author":"Moon","year":"2007","journal-title":"Experimental and Molecular Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0475","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1111\/j.1365-2222.2008.03099.x","article-title":"TACI-Ig prevents the development of airway hyperresponsiveness in a murine model of asthma","volume":"38","author":"Bilsborough","year":"2008","journal-title":"Clinical and Experimental Allergy"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0480","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1084\/jem.20062567","article-title":"BAFF and MyD88 signals promote a lupuslike disease independent of T cells","volume":"204","author":"Groom","year":"2007","journal-title":"Journal of Experimental Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0485","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/eji.201040436","article-title":"TNF superfamily member 13, APRIL, inhibits allergic lung inflammation","volume":"41","author":"Xiao","year":"2011","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0490","doi-asserted-by":"crossref","first-page":"7164","DOI":"10.4049\/jimmunol.177.10.7164","article-title":"Airway epithelial cells produce B cell-activating factor of TNF family by an IFN-beta-dependent mechanism","volume":"177","author":"Kato","year":"2006","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0495","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jaci.2008.11.022","article-title":"Local release of B cell-activating factor of the TNF family after segmental allergen challenge of allergic subjects","volume":"123","author":"Kato","year":"2009","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0500","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jaci.2008.03.002","article-title":"Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps","volume":"121","author":"Kato","year":"2008","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0505","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3345\/kjp.2010.53.8.795","article-title":"Increased B cell-activating factor (BAFF) level in the sputum of children with asthma","volume":"53","author":"Jee","year":"2010","journal-title":"Korean Journal of Pediatrics"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0510","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000094897","article-title":"B cell-activating factor is a novel diagnosis parameter for asthma","volume":"141","author":"Kang","year":"2006","journal-title":"International Archives of Allergy and Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0515","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1398-9995.2007.01566.x","article-title":"SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma","volume":"63","author":"Lei","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0520","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/gene.2011.55","article-title":"Rare mutations in TNFRSF13B increase the risk of asthma symptoms in Swedish children","volume":"13","author":"Janzi","year":"2012","journal-title":"Genes and Immunity"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0525","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","article-title":"TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease","volume":"404","author":"Gross","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0530","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/j.1582-4934.2009.00817.x","article-title":"Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice","volume":"14","author":"Ding","year":"2010","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0535","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/intimm\/dxh287","article-title":"Expression and function of TNF family member B cell-activating factor in the development of autoimmune arthritis","volume":"17","author":"Zhang","year":"2005","journal-title":"International Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0540","doi-asserted-by":"crossref","first-page":"14993","DOI":"10.1073\/pnas.0806044105","article-title":"Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis","volume":"105","author":"Lai Kwan Lam","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0545","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1002\/eji.200838640","article-title":"APRIL (TNFSF13) regulates collagen-induced arthritis, IL-17 production and Th2 response","volume":"38","author":"Xiao","year":"2008","journal-title":"European Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0550","article-title":"The TNF family member APRIL dampens collagen-induced arthritis","author":"Fernandez","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0555","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2249.2010.04293.x","article-title":"Therapeutic effects of TACI-Ig on rat with adjuvant arthritis","volume":"163","author":"Wang","year":"2011","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0560","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejphar.2011.01.002","article-title":"Therapeutic effects of TACI-Ig on collagen-induced arthritis by regulating T and B lymphocytes function in DBA\/1 mice","volume":"654","author":"Liu","year":"2011","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0565","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/nep.12032","article-title":"Serum BAFF and APRIL might be associated with disease activity and kidney damage in patients with anti-GBM disease","volume":"18","author":"Xin","year":"2013","journal-title":"Nephrology (Carlton, Vic.)"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0570","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jneuroim.2008.05.010","article-title":"Serum BAFF expression in patients with myasthenia gravis","volume":"199","author":"Kim","year":"2008","journal-title":"Journal of Neuroimmunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0575","doi-asserted-by":"crossref","first-page":"E755","DOI":"10.1210\/jc.2011-2614","article-title":"Serum BAFF concentrations in patients with Graves\u2019 disease and orbitopathy before and after immunosuppressive therapy","volume":"97","author":"Vannucchi","year":"2012","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0580","doi-asserted-by":"crossref","first-page":"c339","DOI":"10.1159\/000323393","article-title":"Serum levels of BAFF and APRIL in myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated renal vasculitis: association with disease activity","volume":"118","author":"Nagai","year":"2011","journal-title":"Nephron: Clinical Practice"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0585","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2012-202775","article-title":"Tabalumab, an anti-BAFF monoclonal antibody, in patients with active rheumatoid arthritis with an inadequate response to TNF inhibitors","author":"Genovese","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0590","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/art.37820","article-title":"Tabalumab in patients with rheumatoid arthritis with an inadequate response to methotrexate and naive to biologic therapy","volume":"65","author":"Genovese","year":"2013","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0595","first-page":"S545","article-title":"Changes in B cell populations and serum immunoglobulins and their relationship to infections in a one year, uncontrolled open label study of tabalumab. ACR meeting","volume":"64","author":"Greenwald","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0600","first-page":"S193","article-title":"Long-term safety and efficacy of tabalumab, an anti-B-cell activating factor monoclonal antibody, in patients with rheumatoid arthritis: a 52-week, open-label extension study. ACR meeting","volume":"64","author":"Greenwald","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0605","unstructured":"Blisibimod. A-623. Anthera Pharmaceuticals, Inc. BAFF peptibody for the treatment of lupus. Viewed 19 February 2013 <http:\/\/www.anthera.com\/products_a623.asp>."},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0610","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/iub.1046","article-title":"BAFF\/BLyS inhibitors: a new prospect for treatment of systemic lupus erythematosus","volume":"64","author":"Fairfax","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0615","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0620","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1002\/art.30613","article-title":"A phase 3, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits BLyS, in patients with systemic lupus erythematosus","volume":"63","author":"Furie","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0625","first-page":"S1110","article-title":"Sustained disease improvement and safety profile over 1745 patient-year experience (7 years) with belimumab in systemic lupus erythematosus patients","volume":"64","author":"Merrill","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0630","first-page":"S710","article-title":"Belimumab (BmAb), a fully human monoclonal antibody to B-lymphocyte stimulator (BLyS), combined with standard of care therapy reduces the signs and symptoms of rheumatoid arthritis in a heterogeneous subject population","volume":"52","author":"McKay","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0635","first-page":"S926","article-title":"Efficacy of belimumab on non-malignant parotid swelling and systemic manifestations of Sj\u00f6gren's syndrome: results of the Beliss study","volume":"64","author":"De Vita","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0640","first-page":"S1079","article-title":"Results of the Beliss study, the first open phase 2 study of belimumab in primary Sjogren's syndrome","volume":"64","author":"Mariette","year":"2012","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0645","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00228-007-0311-7","article-title":"Safety, pharmacokinetics and pharmacodynamics of atacicept in healthy volunteers","volume":"63","author":"Munafo","year":"2007","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0650","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.4049\/jimmunol.180.6.3655","article-title":"Cutting edge: the dependence of plasma cells and independence of memory B cells on BAFF and APRIL","volume":"180","author":"Benson","year":"2008","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0655","first-page":"2887","article-title":"APRIL secreted by neutrophils binds to heparan sulfate proteoglycans to create plasma cell niches in human mucosa","volume":"118","author":"Huard","year":"2008","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0660","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/toxsci\/kfn105","article-title":"Nonclinical safety, pharmacokinetics, and pharmacodynamics of atacicept","volume":"105","author":"Carbonatto","year":"2008","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0665","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.4049\/jimmunol.173.5.3524","article-title":"Mechanism of action of transmembrane activator and calcium modulator ligand interactor-Ig in murine systemic lupus erythematosus","volume":"173","author":"Ramanujam","year":"2004","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0670","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1172\/JCI26385","article-title":"Similarities and differences between selective and nonselective BAFF blockade in murine SLE","volume":"116","author":"Ramanujam","year":"2006","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0675","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1074-7613(01)00183-2","article-title":"TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS","volume":"15","author":"Gross","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0680","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1002\/art.23047","article-title":"Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating trial","volume":"56","author":"Dall\u2019Era","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0685","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0961203309102803","article-title":"An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus","volume":"18","author":"Pena-Rossi","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0690","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1186\/ar3738","article-title":"Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial","volume":"14","author":"Ginzler","year":"2012","journal-title":"Arthritis Research and Therapy"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0695","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1002\/art.30372","article-title":"Atacicept in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase II, randomized, placebo-controlled trial","volume":"63","author":"van Vollenhoven","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0700","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/art.30373","article-title":"Atacicept in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor antagonist therapy: results of a phase II, randomized, placebo-controlled, dose-finding trial","volume":"63","author":"Genovese","year":"2011","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0705","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/art.23178","article-title":"Atacicept in patients with rheumatoid arthritis: results of a multicenter, phase Ib, double-blind, placebo-controlled, dose-escalating, single- and repeated-dose study","volume":"58","author":"Tak","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"Suppl. 3","key":"10.1016\/j.cytogfr.2013.04.003_bib0710","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/annrheumdis-2012-eular.2055","article-title":"Safety and efficacy of atacicept in combination with rituximab in patients with rheumatoid arthritis: results from the atacicept for reduction of signs and symptoms in rheumatoid arthritis trial (III)","volume":"71","author":"Van Vollenhoven","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0715","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/annrheumdis-2012-202545","article-title":"Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective","volume":"72","author":"Vincent","year":"2012","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0720","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/ard.2007.083162","article-title":"Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus","volume":"67","author":"Albert","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0725","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1189\/jlb.1008659","article-title":"Functional implication of BAFF synthesis and release in gangliosides-stimulated microglia","volume":"86","author":"Kim","year":"2009","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0730","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/art.24628","article-title":"Systemic activation of the immune system induces aberrant BAFF and APRIL expression in B cells in patients with systemic lupus erythematosus","volume":"60","author":"Chu","year":"2009","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0735","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1182\/blood-2011-01-332940","article-title":"Production of the plasma-cell survival factor a proliferation-inducing ligand (APRIL) peaks in myeloid precursor cells from human bone marrow","volume":"118","author":"Matthes","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0740","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-3083.2007.02049.x","article-title":"B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjogren's syndrome","volume":"67","author":"Lavie","year":"2008","journal-title":"Scandinavian Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0745","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cyto.2008.06.005","article-title":"Effect of interleukin-2 on synthesis of B cell activating factor belonging to the tumor necrosis factor family (BAFF) in human peripheral blood mononuclear cells","volume":"44","author":"Suzuki","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0750","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.4049\/jimmunol.1201905","article-title":"HIV-1 gp120 impairs the induction of B cell responses by TLR9-activated plasmacytoid dendritic cells","volume":"189","author":"Chung","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0755","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1182\/blood-2003-06-1984","article-title":"BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone","volume":"103","author":"Moreaux","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0760","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1189\/jlb.0412210","article-title":"Induction of BAFF expression by IFN-gamma via JAK\/STAT signaling pathways in human intestinal epithelial cells","volume":"93","author":"Woo","year":"2013","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0765","doi-asserted-by":"crossref","first-page":"5948","DOI":"10.4049\/jimmunol.0901186","article-title":"Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development","volume":"183","author":"Alexaki","year":"2009","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0770","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/oby.2011.165","article-title":"B cell-activating factor controls the production of adipokines and induces insulin resistance","volume":"19","author":"Hamada","year":"2011","journal-title":"Obesity (Silver Spring, Md.)"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0775","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1038\/emm.2013.4","article-title":"B-cell-activating factor is a regulator of adipokines and a possible mediator between adipocytes and macrophages","volume":"45","author":"Kim","year":"2013","journal-title":"Experimental and Molecular Medicine"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0780","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1210\/en.2011-1504","article-title":"B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies","volume":"153","author":"Alexaki","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0785","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1089\/ten.tea.2011.0316","article-title":"APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1\/2 MAP kinase","volume":"18","author":"Zonca","year":"2012","journal-title":"Tissue Engineering Part A"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0790","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/sj.leu.2404228","article-title":"BAFF and APRIL as osteoclast-derived survival factors for myeloma cells: a rationale for TACI-Fc treatment in patients with multiple myeloma","volume":"20","author":"Abe","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0795","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2004-11-4512","article-title":"The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature","volume":"106","author":"Moreaux","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0800","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.4049\/jimmunol.1102891","article-title":"APRIL binding to BCMA activates a JNK2-FOXO3-GADD45 pathway and induces a G2\/M cell growth arrest in liver cells","volume":"189","author":"Notas","year":"2012","journal-title":"Journal of Immunology"},{"key":"10.1016\/j.cytogfr.2013.04.003_bib0805","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1155\/2011\/108631","article-title":"Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas","volume":"34","author":"Pelekanou","year":"2011","journal-title":"Analytical Cellular Pathology"}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610113000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610113000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T20:44:54Z","timestamp":1563050694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610113000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":161,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1359610113000312"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2013.04.003","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The BAFF\/APRIL system: Emerging functions beyond B cell biology and autoimmunity","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2013.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}